BlackRock Fund Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $5.48M | Buy |
1,178,520
+154,324
| +15% | +$718K | ﹤0.01% | 2890 |
|
|
2016
Q3 | $7.93M | Buy |
1,024,196
+55,209
| +6% | +$427K | ﹤0.01% | 2595 |
|
|
2016
Q2 | $5.87M | Sell |
968,987
-12,558
| -1% | -$76.1K | ﹤0.01% | 2700 |
|
|
2016
Q1 | $8.36M | Buy |
981,545
+22,712
| +2% | +$194K | ﹤0.01% | 2460 |
|
|
2015
Q4 | $11.4M | Buy |
958,833
+26,779
| +3% | +$319K | ﹤0.01% | 2367 |
|
|
2015
Q3 | $9.4M | Buy |
932,054
+1,724
| +0.2% | +$17.4K | ﹤0.01% | 2409 |
|
|
2015
Q2 | $15.4M | Buy |
930,330
+120,629
| +15% | +$2M | ﹤0.01% | 2270 |
|
|
2015
Q1 | $12.5M | Buy |
809,701
+45,977
| +6% | +$712K | ﹤0.01% | 2323 |
|
|
2014
Q4 | $12.1M | Buy |
763,724
+212,553
| +39% | +$3.37M | ﹤0.01% | 2341 |
|
|
2014
Q3 | $5.88M | Sell |
551,171
-15,816
| -3% | -$169K | ﹤0.01% | 2654 |
|
|
2014
Q2 | $5.32M | Buy |
566,987
+107,926
| +24% | +$1.01M | ﹤0.01% | 2798 |
|
|
2014
Q1 | $3.17M | Buy |
459,061
+10,616
| +2% | +$73.3K | ﹤0.01% | 3040 |
|
|
2013
Q4 | $1.75M | Buy |
448,445
+5,410
| +1% | +$21.1K | ﹤0.01% | 3153 |
|
|
2013
Q3 | $2.23M | Buy |
443,035
+153,719
| +53% | +$775K | ﹤0.01% | 3109 |
|
|
2013
Q2 | $1.85M | Buy |
+289,316
| New | +$1.85M | ﹤0.01% | 3109 |
|